Athersys (ATHX) Tops Q4 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil steadies on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Five things to watch in markets in the week ahead
- Citi sees room for further equities upside in 2027 on resilient earnings growth
- Alaska LNG shipping savings justifies billions in investment, developer says
- Citi cuts investment banking analyst program to two years - Bloomberg
- Wall St set for muted open as tech stocks take a breather
- Schneider Electric to buy US software firm PTC in $22.6 billion deal
- Iran's oil minister resigns for personal reasons, state media reports
Athersys Reports Fourth Quarter and 2015 Annual Results
March 10, 2016 4:06 PM ESTCLEVELAND, March 10, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) today announced its financial results for the fourth quarter and year ended December 31, 2015.
Overall, we have made substantial progress over the past twelve months, said Gil Van Bokkelen, Chairman and Chief Executive Officer of Athersys. We have seen that MultiStem® treatment has the potential to help ischemic stroke victims, especially those who can be treated within 36 hours following the stroke. We have identified a promising path forward for continued development through a new partnership in Japan that is well positioned to take advantage of... More



